Altasciences Fills Need of Leading Cancer Therapeutic Drug Developer
Towards a Universal Bioanalytical Workflow for VAMS
Quantitation of the Monoclonal Antibody Rituximab Using VAMS, Impact-Assisted Extraction, Trypsin Digestion and LC-MRM
Stability of ASO in Tissue Matrix
Resolving Issues with Matrix Effect Oligonucleotides
Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects
Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy
Vaccine Development Blog/Podcast
.custom-column-left-text {
float: left;
width: 50%;
padding-right: 10px;
}
.custom-column-right-text {
float: right;
width: 45%;
text-align:center;
}
@media only screen and (max-width: 600px) {
.custom-column-left-text,
.custom-column-right-text,
.custom-column-flc-ebook-text {
float:none;
width:80%;
margin:0 auto;
}
}